NDC 0054-0652

Vigabatrin

Vigabatrin

Vigabatrin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc. The primary component is Vigabatrin.

Product ID0054-0652_5ed8d293-b7d8-4c66-9c31-8075e6f99092
NDC0054-0652
Product TypeHuman Prescription Drug
Proprietary NameVigabatrin
Generic NameVigabatrin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-09-09
Marketing CategoryANDA /
Application NumberANDA213104
Labeler NameHikma Pharmaceuticals USA Inc
Substance NameVIGABATRIN
Active Ingredient Strength500 mg/1
Pharm ClassesAnti-epileptic Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0054-0652-25

100 TABLET in 1 BOTTLE (0054-0652-25)
Marketing Start Date2022-09-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Vigabatrin" or generic name "Vigabatrin"

NDCBrand NameGeneric Name
0054-0652VigabatrinVigabatrin
0574-0201VIGABATRINvigabatrin
0574-0470VIGABATRINvigabatrin
0591-3851VigabatrinVigabatrin
0591-3955vigabatrinvigabatrin
16729-521VigabatrinVigabatrin
42799-950VigabatrinVigabatrin
43598-651VigabatrinVigabatrin
43598-697VigabatrinVigabatrin
49884-358VIGABATRINvigabatrin
59651-366VigabatrinVigabatrin
59651-367VigabatrinVigabatrin
64850-940Vigabatrinvigabatrin
69238-1425VigabatrinVigabatrin
69097-964VIGABATRINVIGABATRIN
67877-674VIGABATRINVIGABATRIN
67386-111SABRILvigabatrin
67386-211SABRILvigabatrin
31722-009vigabatrin for oral solutionvigabatrin
0054-0702Vigabatrin for oral solution USP, 500 mgVigabatrin
0245-0556VIGADRONEvigabatrin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.